The results showed that those taking semaglutide were 42% less likely to end up in hospital or die prematurely, compared with a proxy for placebo
But it primarily depends on individual treatment plans
Contraindications:: Patients with a personal or family history of medullary thyroid carcinoma (based upon animal data - see FDA Warning) History of hypersensitivity to semaglutide or any of its excipients (serious reactions including angioedema & anaphylaxis have been reported) Side Effects: GI Adverse events: nausea, vomiting, constipation, diarrhea (~5-15%) most GI side side effects occur during dose initiation or escalation and wane after a few weeks (Drucker, 2024)
Perimenopause brain fog responds particularly well to adaptogens like rhodiola and ashwagandha, which address the cortisol dysregulation driven by hormonal fluctuations
Important: Wegovy Is NOT Approved for OSA Unlike Zepbound (tirzepatide) , which was FDA-approved for obstructive sleep apnea (OSA) in December 2024, Wegovy is not approved for OSA
